International travel patterns and travel risks for stem cell transplant recipients

Journal of Travel Medicine

Volumn 22, Issue 1, 2015, Pages 39-47

  Mikati, Tarek ^a,b   Griffin, Kenneth ^b   Lane, Dakotah ^c   Matasar, Matthew ^a,c   Shah, Monika K ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Public Health ^*  (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIVIRUS AGENT; HEPATITIS A VACCINE; INFLUENZA VACCINE; INSECT REPELLENT; POLIOMYELITIS VACCINE; RABIES VACCINE; TYPHOID VACCINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANADA; CARIBBEAN; CAUCASIAN; CENTRAL AMERICA; CROSS-SECTIONAL STUDY; DIARRHEA; EMPORIATRICS; ETHNICITY; FEMALE; HAZARD RATIO; HEALTH HAZARD; HELP SEEKING BEHAVIOR; HEPATITIS A; HUMAN; INCIDENCE; INCOME; INFLUENZA; MAJOR CLINICAL STUDY; MALARIA; MALE; MEXICO; MIDDLE AGED; NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; PATIENT COUNSELING; PLASMA CELL DYSCRASIA; POLIOMYELITIS; PROPORTIONAL HAZARDS MODEL; RABIES; RECIPIENT; STEM CELL TRANSPLANTATION; TOURISM; TRAVEL; TRAVELLER DIARRHEA; TYPHOID FEVER; UNITED STATES; WESTERN EUROPE; YOUNG ADULT; ADOLESCENT; AGED; ATTITUDE TO HEALTH; CHEMOPROPHYLAXIS; COMMUNICABLE DISEASES; GRAFT RECIPIENT; INTERNATIONAL COOPERATION; PATIENT ATTITUDE; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANADA; CHEMOPREVENTION; COMMUNICABLE DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCIDENCE; INTERNATIONALITY; MALARIA; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; STEM CELL TRANSPLANTATION; TRANSPLANT RECIPIENTS; TRAVEL; UNITED STATES; YOUNG ADULT;

EID: 84936781383     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12166     Document Type: Article

References (35)

1. Ryan ET, Wilson ME, Kain KC,. Illness after international travel. N Engl J Med 2002; 347: 505-516.
2. Hill DR,. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 2000; 7: 259-266.
3. International Trade Administration, Office of Travel and Tourism Industries, US Department of Commerce. United States resident travelers visiting overseas destinations: 2010 outbound. Available at: http://tinet.ita.doc.gov/outreach. (Accessed 2012 Sep 24).
4. McCarthy AE, Mileno MD,. Prevention and treatment of travel-related infections in compromised hosts. Curr Opin Infect Dis 2006; 19: 450-455.
5. Uslan DZ, Patel R, Virk A,. International travel and exposure risks in solid-organ transplant recipients. Transplantation 2008; 86: 407-412.
6. Salit IE, Sano M, Boggild AK, Kain KC,. Travel patterns and risk behaviour of HIV-positive people travelling internationally. CMAJ 2005; 172: 884-888.
7. Roukens AH, van Dissel JT, de Fijter JW, Visser LG,. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transplant 2007; 21: 567-570.
8. Boggild AK, Sano M, Humar A, et al. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 2004; 11: 37-43.
9. Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987; 156: 84-91.
10. Hill DR,. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 2000; 7: 259-266.
11. Centers for Disease Control and Prevention, Jong EC, Freedman DO,. CDC health information for the international traveler. New York: Oxford University Press, 2012.
12. National Institute of Health. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143-1238.
13. Weissman S, Feucht C, Moore BA,. Response to hepatitis A vaccine in HIV-positive patients. J Viral Hepat 2006; 13: 81-86.
14. Overton ET, Nurutdinova D, Sungkanuparph S, et al. Predictors of immunity after hepatitis A vaccination in HIV-infected persons. J Viral Hepat 2007; 14: 189-193.
15. Galea S, Tracy M,. Participation rates in epidemiologic studies. Ann Epidemiol 2007; 17: 643-653.
16. Mileno MD, Bia FJ,. The compromised traveler. Infect Dis Clin North Am 1998; 12: 369-412.
17. Pasquini MC, Wang Z. Current use and outcome of hematopoeitic stem cell transplantation: CIBMTR summary slides. 2012. Available at: http://www.cibmtr.org (Accessed 2012 Sep 15.)
18. dos Santos CC, Anvar A, Keystone JS, Kain KC,. Survey of use of malaria prevention measures by Canadians visiting India. CMAJ 1999; 160: 195-200.
19. Correia JD, Shafer RT, Patel V, et al. Blood and body fluid exposure as a health risk for international travelers. J Travel Med 2001; 8: 263-266.
20. Jacobsen KH, Wiersma ST,. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28: 6653-6657.
21. Crump JA, Luby SP, Mintz ED,. The global burden of typhoid fever. Bull World Health Organ 2004; 82: 346-353.
22. Kaplan LJ, Daum RS, Smaron M, McCarthy CA,. Severe measles in ICD patients. JAMA 1992; 267: 1237-1241.
23. Centers for Disease Control and Prevention. Measles: United States, January-May 20, 2011. MMWR 2011; 60: 666-668.
24. Muscat M, Bang H, Wohlfahrt J, et al. Measles in Europe: an epidemiological assessment. Lancet 2009; 373: 383-389.
25. Pauksen K, Duraj V, Ljungman P, et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427-432.
26. Ljungman P, Fridell E, Lonnqvist B, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610-615.
27. Machado CM, Goncalves FB, Pannuti CS, et al. Measles in bone marrow transplant recipients during an outbreak in Sao Paulo, Brazil. Blood 2002; 99: 83-87.
28. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354: 119-130.
29. Centers for Disease Control and Prevention. Travel-associated Dengue surveillance-United States, 2006-2008. MMWR 2010; 59: 715-719.
30. Kotton CN,. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007; 44: 857-866.
31. Matteelli A, Carosi G,. Sexually transmitted diseases in travelers. Clin Infect Dis 2001; 32: 1063-1067.
32. Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44: 521-526.
33. Rubin L, Levin M, Ljungman P, et al. IDSA practice guidelines for vaccination of the immunocompromised host. Clin Infect Dis 2013; 2013: 1-57.
34. Bacaner N, Stauffer B, Boulware DR, et al. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 2004; 291: 2856-2864.
35. Leder K, Tong S, Weld L, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006; 43: 1185-1193.